The aim of the present study was to compare the proteins IL-10 and H-FABP to the well-studied proteins S100β, GFAP, and NF-L for their individual ability to predict patients who will have favorable long-term outcome analyzing patients on a clinically meaningful allocation basis: patients with mTBI and patients with TBIs of all severities. This evidence concerns the gene NEFL and concussion.